Alto

The start-up, based in San Francisco, leverages its platform to assist users in streamlining communication with doctors and insurance providers to obtain their prescribed medications. Initially established as ScriptDash in 2015, the company underwent a rebranding in 2017 after securing $23 million in funding from investors like Greenoaks Capital and Jackson Square Ventures. Alto further achieved notable financial milestones, accumulating $20 million through series B funding in 2017, $50 million through series C funding in 2018, and a substantial $250 million through series D funding in 2020. These successful funding rounds cumulatively raised Altos total investment to over $350 million.